# Intracoronary Administration of Levosimendan in Cardiac Surgery Patients

> **NCT01500785** · PHASE4 · TERMINATED · sponsor: **Tampere University Hospital** · enrollment: 50 (actual)

## Conditions studied

- Myocardial Stunning

## Interventions

- **DRUG:** levosimendan
- **DRUG:** Vitamin B 12

## Key facts

- **NCT ID:** NCT01500785
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-06-15
- **Primary completion:** 2018-12-15
- **Final completion:** 2019-09-11
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Change of schedule
- **Last updated:** 2019-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01500785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01500785, "Intracoronary Administration of Levosimendan in Cardiac Surgery Patients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01500785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*